PMC's Annual Award for Leadership in Personalized Medicine

Jay Flatley, Executive Chairman, Illumina (right), accepts the 13th Annual Award for Leadership in Personalized Medicine from Paul R. Billings, M.D., Ph.D., Chairman, Biological Dynamics, at Harvard Medical School.

Nomination Period Now Closed

Thank you to all those who nominated a candidate for the 14th Annual Award for Leadership in Personalized Medicine. The award winner will share his or her vision for the future of personalized medicine at the 14th Annual Personalized Medicine Conference at Harvard Medical School from November 14 - 15, 2018.

The nomination period for the 15th Annual Award for Leadership in Personalized Medicine will open in March of 2019.

About the Award

The Annual Award for Leadership in Personalized Medicine recognizes an individual whose contributions in science, business and/or policy have helped advance the frontiers of personalized medicine.

Previous award recipients include:

  • Jay T. Flatley (2017)
    Executive Chairman
  • Raju Kucherlapati, Ph.D. (2016)
    Paul C. Cabot Professor of Genetics
    Harvard Medical School
  • Francis S. Collins, M.D., Ph.D. (2015)
    National Institutes of Health (NIH)
  • Mark Levin (2014)
    Co-founder, Partner
    Third Rock Ventures
  • Kathy Giusti (2013)
    Founder, Chief Executive Officer
    Multiple Myeloma Research Foundation and Multiple Myeloma Research Consortium
  • Randal W. Scott, Ph.D. (2012)
    InVitae Corporation
  • Leroy Hood, Ph.D., M.D. (2011)
    Institute for Systems Biology
  • William S. Dalton, Ph.D., M.D. (2010)
    DeBartolo Family Personalized Medicine Institute at Moffitt Cancer Center
  • Brook Byers (2009)
    Managing Partner
    Kleiner Perkins Caufield & Byers (KPCB)
  • Michael O. Leavitt (2008)
    Founder and Chairman
    Leavitt Partners
  • Ralph Snyderman, M.D. (2007)
    Chancellor Emeritus
    Duke University
    Founder and Chairman
    Proventys, Inc.
  • Elizabeth G. Nabel, M.D. (2006)
    Brigham and Women's Health Care
  • Janet Woodcock, M.D. (2005)
    FDA Center for Drug Evaluation and Research